Element Biosciences Revenue and Competitors

Location

$401M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Element Biosciences's estimated annual revenue is currently $83.3M per year.(i)
  • Element Biosciences's estimated revenue per employee is $217,000
  • Element Biosciences's total funding is $401M.

Employee Data

  • Element Biosciences has 384 Employees.(i)
  • Element Biosciences grew their employee count by 2% last year.

Element Biosciences's People

NameTitleEmail/Phone
1
Staff Study ManagerReveal Email/Phone
2
Research Associate, Systems IntegrationReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$4280M11139-4%$28M$63.3B
#2
$38.1M3141%N/A$559.2M
Add Company

What Is Element Biosciences?

Element Biosciences is a multi-disciplinary startup focused on innovating genetic analysis tools for the research and diagnostic markets. The Company's technology will broaden the end user experience through improved data quality and simplified workflows to benefit discoveries and diagnosis in healthcare.

keywords:N/A

$401M

Total Funding

384

Number of Employees

$83.3M

Revenue (est)

2%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Element Biosciences News

2022-04-06 - NGS Upstarts Expected to Take On the Champion

Element Biosciences, a developer of genetic analysis tools for the research and diagnostic markets, was co-founded by Molly He, PhD, Mike...

2022-03-22 - Old Dogs, New Tricks: Element Biosciences Launches the AVITI

“Stealth mode” barely scratches the surface of Element Biosciences's secrecy over the past few years. More accurate would be Game of Thrones...

2022-03-22 - Element Biosciences Partners With Genoox

Element Biosciences Partners with Genoox. Aims to demonstrate the clinical potential of the AVITI system for rare and undiagnosed disease...

2021-07-01 - Element Biosciences Raises $276M in Series C Financing

Element Biosciences, a San Diego, CA-based developer of a DNA sequencing platform, closed a $276m Series C financing. Backers included new investors Janus Henderson Investors, Logos Capital, Meritech Capital Partners, Counterpoint Global (Morgan Stanley), and T. Rowe Price and existing investor ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$133.7M3841%N/A
#2
$101.1M3850%N/A
#3
$139.9M3864%N/A
#4
$48.3M386-1%N/A
#5
$130.6M387-9%N/A